| Pharmaceutical Information |
| Drug Name |
Dexmethylphenidate |
| Drug ID |
BADD_D02457 |
| Description |
Dexmethylphenidate is the dextrorotary form of methylphenidate introduced in 2002[A177181]. It is a norepinephrine-dopamine reuptake inhibitor (NDRI) and thus a psychostimulant[A177193]. It is used for treatment of Attention Deficit Hyperactivity Disorder (ADHD)[Label,A177181]. The d-isomer is thought to have greater effect with fewer side effects than the l-isomer or the racemic mixture[A177181]. |
| Indications and Usage |
Dexmethylphenidate is used as a treatment for ADHD, ideally in conjunction with psychological, educational, behavioral or other forms of treatment[A177187,Label]. |
| Marketing Status |
approved; investigational |
| ATC Code |
N06BA11 |
| DrugBank ID |
DB06701
|
| KEGG ID |
D07806
|
| MeSH ID |
D064699
|
| PubChem ID |
154101
|
| TTD Drug ID |
D02QCD
|
| NDC Product Code |
Not Available |
| UNII |
M32RH9MFGP
|
| Synonyms |
Dexmethylphenidate Hydrochloride | Hydrochloride, Dexmethylphenidate | Focalin XR | XR, Focalin | Dexmethylphenidate | Focalin |
|
| Chemical Information |
| Molecular Formula |
C14H19NO2 |
| CAS Registry Number |
40431-64-9 |
| SMILES |
COC(=O)C(C1CCCCN1)C2=CC=CC=C2 |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
